Literature DB >> 178461

Enhanced aldosterone response to angiotensin II in human hypertension.

E S Kisch, R G Dluhy, G H Williams.   

Abstract

Adrenal and vascular responsiveness to graded doses of angiotensin II (A II) were recorded for seven normal subjects and 12 patients with essential hypertension while in balance on an intake of 200 mEq sodium/100 mEq potassium. Patients with essential hypertension had been previously studied and known to have normal responses of plasma renin activity to sodium restriction and upright posture. A II was administered for 30 minutes at rates of 0.1, 0.3, 1, and 3 ng/kg per minute and plasma aldosterone responses were assessed 20 and 30 minutes later; blood pressure was monitored at intervals of 1 minute during infusion of A II at each rate. A significant increment in plasma aldosterone occurred at an infusion rate of 0.3 ng/kg per minute in patients with hypertension. This change was not seen until the infusion rate reached 1.0 ng/kg per minute in the normotensive control subjects. Even at an A II infusion rate of 1 ng/kg per minute, the increment in plasma aldosterone levels in normotensive subjects (4.2 +/- 0.6 ng/dl) was significantly less (P less than 0.001) than that in patients with essential hypertension (19 +/- 3 ng/dl). In both groups, a significant rise in mean arterial blood pressure occurred at an A II dose of 0.3 ng/kg per minute, but the pressor response of the hypertensive group was significantly greater at the highest infusion rate (3 ng/kg per minute) (P less than 0.05). Thus, enhanced adrenal and pressor responsiveness to infused A II was observed in the hypertensive subjects, suggesting a change in A II receptor affinity.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 178461     DOI: 10.1161/01.res.38.6.502

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  7 in total

1.  The adrenal receptor for angiotensin II is altered in essential hypertension.

Authors:  G H Williams; N K Hollenberg; T J Moore; S L Swartz; R G Dluhy
Journal:  J Clin Invest       Date:  1979-03       Impact factor: 14.808

2.  Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension.

Authors:  M Wisgerhof; R D Brown
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

3.  Cardiovascular and adrenal sensitivity to angiotensin II in essential hypertension.

Authors:  G Wambach; U Meiners; G Bönner; A Konrads; A Helber
Journal:  Klin Wochenschr       Date:  1984-12-03

4.  Decreased adrenal responsiveness to angiotensin II: a defect present in spontaneously hypertensive rats. A possible model of human essential hypertension.

Authors:  G H Williams; L M Braley; A Menachery
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

5.  Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension.

Authors:  R G Dluhy; S Z Bavli; F K Leung; H S Solomon; T J Moore; N K Hollenberg; G H Williams
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

6.  Rapid increase of mineralocorticoids after furosemide in low-renin essential hypertension: evidence for 18-hydroxycorticosterone to be a better marker than aldosterone.

Authors:  H Witzgall; G Thayil; P C Weber
Journal:  Klin Wochenschr       Date:  1982-08-16

7.  Renin-hyporesponsiveness in essential hypertension. Dissociation between plasma renin and catecholamines or aldosterone following furosemide.

Authors:  C Beretta-Piccoli; P Weidmann; G Keusch; M Grimm; A Meier; Z Glück; W H Ziegler
Journal:  Klin Wochenschr       Date:  1980-05-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.